113 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
as through physician-directed or standing order prescriptions at retail pharmacies, health departments, local law enforcement agencies, community-based
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
to in advance in writing by the Board or listed on Appendix A; (B) personally engage in civic, charitable, or community services; and (C) personally own
8-K
EX-99.1
oczo3m9mxrd93 wit
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
778pjbd
30 Aug 23
Other Events
6:30am
8-K
EX-99.1
sj6om18v9iex8lg
30 May 23
Entry into a Material Definitive Agreement
7:32am
424B5
jsaphgso 6ype49v7
18 May 23
Prospectus supplement for primary offering
7:45am
DEFR14A
zj8pn
24 Apr 23
Revised proxy
9:32am
8-K
EX-99.1
ec3o t9pawdl0
29 Mar 23
Regulation FD Disclosure
9:29am
8-K
EX-99.1
xg1fmjjjju67 6hr
6 Dec 22
Regulation FD Disclosure
7:01am
8-K
EX-99.1
0yjn vs1wyt
26 Sep 22
Completion of Acquisition or Disposition of Assets
5:05pm
8-K
EX-2
dd9x8juri 9k0
18 May 22
Entry into a Material Definitive Agreement
5:13pm